Issue 1/2001
Content (12 Articles)
Peri‐marketing surveillance of lamotrigine in the Netherlands: Doctors' and patients' viewpoints
D.G.A. Kasteleijn‐Nolst Trenité, K.G.P.M. Gilissen, Th. W Rentmeester, F.B.J. Scholtes, L.R. Arends, A. Schlosser
The perceived role and skills of pharmacists in asthma management after in‐house training
Kirsti K. Vainio, Maarit J.H. Korhonen, K. Hannes Enlund, Anne M. Hirvonen
The role of the community pharmacist in drug abuse: a comparison of service provision between Northern Ireland and England/Wales
Glenda F. Fleming, James C. McElnay, Carmel M. Hughes, Janie Sheridan, John Strang
Pharmacotherapeutical options in inflammatory bowel disease: an update
Y.H. Kho, M. Oudkerk Pool, F.G.A. Jansman, J.W. Harting
"No thank you": Why elderly patients declined to participate in a research study
D.R. Petty, A.G. Zermansky, D.K. Raynor, C.J. Lowe, A.D. Buttress, A. Vail, N. Freemantle
Comparative trials in registration files of cardiovascular drugs: Comparator drugs and dosing schemes.
N.F. Wieringa, R. Vos, P.A. de Graeff
Neuropsychiatric symptoms during cefepime treatment
Willem Diemont, Marius MacKenzie, Nicolaas Sxhaap, Gerard Goverde, Hedwig van Heereveld, Yechiel Hekster, Kees van Grootheest